| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.088 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.096 | 0.08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |